GSK sets up network to help its suppliers cut emissions

GlaxoSmithKline ($GSK) is working to reduce the environmental impact of its supply chain with an information exchange that allows its suppliers to share ideas on how to improve energy efficiency and reduce environmental impacts. According to edie.net, GSK says that 40% of its carbon footprint comes from buying supplies. It is asking 500 suppliers to joint the network and hopes that will result in reducing emissions from its processes by 25%. Story

Suggested Articles

Already developing coronavirus treatments, Takeda struck a licensing deal to manufacture and market Novavax's vaccine candidate in Japan

Pfizer struck a deal to produce Gilead Sciences' remdesivir, which has been running short at some hard-hit U.S. hospitals.

On the heels of last week's deal for 120 million Pfizer-BioNTech shots, Japan has locked down 120 million more vaccines from AstraZeneca.